Google Preview Button

British National Formulary 72 (Bnf)


PublicadoSeptiembre 2016
Peso861 gramos
Dimensiones15 x 21 x 4 cms.
EditorialPharmaceutical Press
PVP sin IVA -

¡Envío GRATIS!
para España y Portugal (Península)

Puede encontrar libros similares en:

Libros | Farmacia

Libros | Medicina | Farmacología


The September 2016 British National Formulary (BNF) provides up-to-date, practical guidance on prescribing, dispensing, and administering medicines. This essential reference reflects current best practice as well as legal and professional guidelines relating to the uses of medicines.

BNF 72 has been revised and revalidated to reflect changes in product availability, emerging safety concerns and shifts in clinical practice. Access to the latest edition of the BNF is vital for healthcare professionals, as there are a large number of updates from one edition to the next.

Some of the significant content updates for BNF 72 include:

  • New safety information about the risk of abnormal pregnancy outcomes with sodium valproate and valproic acid
  • Updated guidance for conditions including asthma, obesity, coeliac disease, irritable bowel syndrome and prostate cancer
  • New drug monographs including edoxaban, albiglutide, dulaglutide, dasabuvir, and vortioxetine
  • Updated pregnancy-prevention advice for patients taking mycophenolate mofetil
  • Updated guidance on the risk of hepatitis B reactivation with BCR-ABL tyrosine kinase inhibitors, and pomalidomide
  • Advice about the risk of ulceration with nicorandil treatment
  • NICE guidelines including the use of vedolizumab for treating moderately to severely active Crohn’s disease
  • New guidance on suspected or confirmed drug allergy
  • Evidence grading of BNF recommendations.

Improvements in the new edition

Since the launch of the new format BNF we have actively sought your comments and feedback, and as a result have made the following improvements to this edition:

  • Important safety information is displayed prominently within the monograph
  • Class monographs (e.g. ACE inhibitors) are easy to navigate to from the individual monographs.

The BNF evaluates clinical evidence from diverse sources with information validated by a network of clinical experts and published under the authority of a Joint Formulary Committee.


Content of the BNF reflects current best practice as well as legal and professional guidelines relating to the uses of medicines. The resource includes:

  • Guidance on the drug management of common conditions
  • Details of medicines prescribed within the UK with special reference to their uses, cautions, contra-indications, side-effects, doses and relative costs. This allows treatment to be tailored to the individual needs of each patient.
  • Guidance on prescribing, monitoring, dispensing and adminstering medicines.

The content is updated every 6 months in print, making it an up-to-date source of prescribing advice for informed decision-making.

Cerrar vista previa